ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Generation Uranium Inc

Generation Uranium Inc (GEN)

0.085
-0.015
( -15.00% )
更新日時: 00:17:20

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
0.085
買値
0.085
売値
0.10
出来高
38,500
0.085 日の範囲 0.10
0.075 52 週間の範囲 0.435
時価総額
前日終値
0.10
始値
0.10
最終取引時間
01:13:26
財務取引量
-
VWAP
-
平均取引量 (3 か月)
37,585
発行済株式数
24,596,000
配当利回り
-
PER
-2.74
1 株当たり利益 (EPS)
-0.03
歳入
-
純利益
-717k

Generation Uranium Inc について

セクター
Gold Ores
業界
Unit Inv Tr, Closed-end Mgmt
ウェブサイト
本社
Richmond, British Columbia, Can
設立
2022
Generation Uranium Inc is listed in the Gold Ores sector of the トロントベンチャー取引所 with ticker GEN. The last closing price for Generation Uranium was $0.10. Over the last year, Generation Uranium shares have traded in a share price range of $ 0.075 to $ 0.435.

Generation Uranium currently has 24,596,000 shares in issue. The market capitalisation of Generation Uranium is $2.46 million. Generation Uranium has a price to earnings ratio (PE ratio) of -2.74.

GEN 最新ニュース

Emerging Markets Report: Piece of Cake

ORLANDO, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Today’s featured company is a simple story. It’s a uranium play. For those of you who have dabbled in the markets for any length of time you may...

Genmab Files IND for HuMax-TF-ADC

Company Announcement IND for HuMax(R)-TF-ADC submitted to FDA Genmab's first IND submission for antibody-drug conjugate (ADC) product Patient enrolment in clinical trial expected...

Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec refused re-hearing in Arzerra patent infringement case COPENHAGEN, Denmark, July 15, 2013 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN...

Genmab Collaborator GSK Starts New Ofatumumab Phase III Study in Rare Skin Disorder

Company Announcement First Phase III study with subcutaneous formulation of ofatumumab Ofatumumab to be investigated in new autoimmune area - pemphigus vulgaris Patient...

Genmab and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhe

Media Release     Antibody-drug conjugate (ADC) to be developed for cancer Combines strength of HuMax(R)-TAC with next generation PBD-based warhead technology 50:50 partnership ...

Teprotumumab Restarts Clinical Development in New Indication

Company Announcement Teprotumumab (RG1507) to be investigated for new indication River Vision Development Corporation to conduct clinical development under a license from Roche...

Genmab Launches Sponsored Level 1 American Depositary Receipt (ADR) Program

Company Announcement Genmab establishes Sponsored Level 1 ADR program Genmab ADRs can be traded on US over-the-counter (OTC) market effective today ADR ticker symbol GMXAY...

GSK and Genmab Announce Positive Top-Line Results From Pivotal Study of ARZERRA(R) (ofatumumab) Combined With Chlorambucil in P

Company Announcement Median 22.4 month progression free survival in patients treated with ofatumumab plus chlorambucil, an improvement of 9.3 months compared to chlorambucil alone No...

Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec have filed for re-hearing in the United States COPENHAGEN, Denmark, May 17, 2013 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced...

Genmab Announces Financial Results for the First Quarter of 2013

COPENHAGEN, Denmark, May 7, 2013 (GLOBE NEWSWIRE) -- Interim Report First Quarter 2013 Arzerra(r) received approval in Japan Arzerra net sales increased 65% over Q1...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.015-150.10.10.085151200.09841272CS
4-0.015-150.10.10.085127900.09733586CS
12-0.155-64.58333333330.240.240.085375850.14505994CS
26-0.225-72.58064516130.310.4350.085396430.23095126CS
52-0.025-22.72727272730.110.4350.075336550.23039679CS
156-0.015-150.10.4350.045175510.22520597CS
260-0.015-150.10.4350.045175510.22520597CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VMY.HVoice Mobility International Inc
$ 0.05
(900.00%)
5k
TVC.HThree Valley Copper Corp
$ 0.01
(100.00%)
1.9k
DEALPlaygon Games Inc
$ 0.015
(50.00%)
21.81k
YAYTHS Maple Holdings Ltd
$ 0.15
(50.00%)
4.5k
CLMConsolidated Lithium Metals Inc
$ 0.015
(50.00%)
5.2k
MTXMetalex Ventures Ltd
$ 0.015
(-50.00%)
42.04k
LET.HLetho Resources Corp
$ 0.025
(-50.00%)
73.5k
ALTAlturas Minerals Corp
$ 0.005
(-50.00%)
10k
BOCABocana Resources Corp
$ 0.005
(-50.00%)
380k
LSD.HLightspeed Discoveries Inc
$ 0.015
(-40.00%)
4k
THRMTherma Bright Inc
$ 0.035
(40.00%)
4.6M
GPUSAlset AI Ventures Inc
$ 0.115
(21.05%)
4.54M
MATEBlockmate Ventures Inc
$ 0.275
(-3.51%)
3.91M
QNCQuantum Emotion Corp
$ 0.54
(-20.59%)
3.64M
BETNorthstar Gaming Holdings Inc
$ 0.035
(40.00%)
1.68M